Effects of Beta Blockade on the Peripheral Manifestations of Thyrotoxicosis
Authors:
- 1 June 1971
- journal article
- clinical trial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 74 (6) , 875-879
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Sotalol: A new, safe beta adrenergic receptor blocking agent∗The American Journal of Cardiology, 1968
- Myocardial and local anesthetic actions of β-adrenergic receptor blocking drugs: Relationship to physicochemical propertiesEuropean Journal of Pharmacology, 1968
- ADRENERGIC BLOCKADE AND THE EYE SIGNS OF THYROTOXICOSISThe Lancet, 1966
- β-ADRENERGIC BLOCKERS IN CHILDHOOD THYROTOXICOSISThe Lancet, 1966
- BETA-SYMPATHETIC BLOCKADE IN HYPERTHYROIDISMThe Lancet, 1966
- New InventionsThe Lancet, 1965
- INOTROPIC AND METABOLIC EFFECTS OF THREE BETA-ADRENERGIC RECEPTOR BLOCKING DRUGS ON ISOLATED RABBIT LEFT ATRIAThe Journal of Pharmacology and Experimental Therapeutics, 1965
- Guanethidine in HyperthyroidismJAMA, 1964
- THE ACHILLES REFLEX A DIAGNOSTIC TEST OF THYROID DYSFUNCTIONThe Lancet, 1963
- PATHOGENESIS OF CIRRHOSIS OF THE LIVER OCCURRING IN PATIENTS WITH DIFFUSE TOXIC GOITERArchives of internal medicine (1960), 1946